Emerging evidence has shown that aberrantly expressed microRNAs (miRNAs) are highly associated with tumour development and progression. However, little is known about the potential role of miRNAs in gastric cancer (GC) metastasis. In this study, miR-409-3p was found to be downregulated frequently in human GCs, and its expression was significantly associated with tumor-node-metastasis (TNM) stage and lymph node metastasis. Enforced expression of miR-409 in GC cells significantly reduced their migration and invasion in vitro and their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo. Moreover, we found that miR-409 exerted its function predominantly through the mature miR-409-3p, but not miR-409-5p. Microarray and bioinformatics analysis identified the pro-metastatic gene radixin (RDX) as a potential miR-409-3p target. Further studies confirmed that miR-409-3p suppressed the expression of RDX by directly binding to its 3 0 -untranslated region. Silencing of RDX by small interfering RNAs phenocopied the effects of miR-409 overexpression, whereas restoration of RDX in miR-409-overexpressed GC cells reversed the suppressive effects of miR-409. Taken together, these results demonstrate that miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX and that patients with downregulated miR-409-3p are prone to lymph node metastasis.
INTRODUCTION
Gastric cancer (GC) is the fourth most common human malignant disease and the second leading cause of cancer-related death worldwide, with particularly high incidence in East Asia. 1 Despite the significant achievements that have been made in the treatment of early GC, the long-term survival rate for advanced GC is still quite low. 2 The major obstacle in the treatment of advanced GC is the presentation of lymphatic, peritoneal or distal organ metastases, which simultaneously predict poor outcome for these patients. 3, 4 Although it has been reported that a large number of oncogenes and tumour suppressors are involved in the development of gastric carcinomas, 5 --7 the molecular mechanisms underlying the invasion and metastasis of advanced gastric carcinomas are still poorly understood.
MicroRNAs (miRNAs) are small non-coding RNAs that function as negative regulators for protein coding genes at the posttranscriptional level. 8 miRNAs can bind to complementary sequences in the 3 0 -untranslated regions (3 0 -UTR) of their target mRNAs and induce mRNA degradation or translational repression. 9 An increasing number of studies indicate that miRNAs are involved in many important biological processes, including proliferation, apoptosis, differentiation, angiogenesis and immune response, with deregulation leading to aberrant gene expression in various diseases. 10 In the last 5 years, compelling evidence has shown that miRNAs have important roles in the initiation and progression of cancers, and the molecules have thus become a hotspot in cancer research. 11, 12 Currently, many miRNAs are reported to be involved in proliferation, Helicobacter pylori infection, multidrug resistance, disease diagnosis and prognosis of GC. 13, 14 However, only a few miRNAs, including miR-218, 15 miR516a-3p, 16 miR-107 17 and Let-7f, 18 are known to be involved in the metastasis of GC. These miRNAs may have the potential to act as either biomarkers or therapeutic targets for advanced GC. We focused on miR-409 to further explore the novel mechanism miRNAs have in advanced GC, because miR-409-3p is highly correlated to the metastatic status of GC patients. 19 However, the biological function of miR-409 in GC metastasis remains unknown.
In this study, we demonstrated that miR-409-3p was frequently downregulated in human GC and was significantly associated with lymph node metastasis in an independent GC cohort. Functional investigation indicated that miR-409 might act as a novel antimetastatic miRNA. Moreover, the potentially prometastatic gene radixin (RDX) was identified as a direct, functional target of miR-409.
RESULTS miR-409-3p is downregulated in GC and is associated with lymph node metastasis A previous microarray study has shown that miRNAs are differentially expressed in GC and that some miRNAs are correlated with the depth of invasion, lymph node metastasis and peritoneal metastasis; 19 however, the functional role of these miRNAs in the metastasis of GC remained unexplored. Cell migration and invasion have an important role in the process of cancer metastasis. In this study, we first selected several miRNAs (miR-9, miR-126, miR-151, miR-199b, miR-218 and miR-409-3p) that exhibited both correlations with depth of invasion and peritoneal dissemination in GC patients. These miRNAs were then subjected to cell migration and invasion assays. Among them, we found that miR-409-3p significantly suppressed GC cell migration and invasion (Supplementary Figure S1) . However, to the best of our knowledge, the biological roles of miR-409-3p in human cancers have not been characterized, so we next sought to determine the roles of miR-409 in GC.
To further confirm the correlation between miR-409-3p expression and metastasis in GC, we first determined the expression of miR-409-3p in 90 paired GCs and their corresponding nontumorous tissue, using quantitative reverse-transcription PCR. We found that miR-409-3p expression was significantly downregulated in GC tissues when compared with the corresponding nontumorous samples (Figures 1a and b) . The correlation between miR-409-3p expression level and the clinicopathological characteristics of GC were summarised in Table 1 . The expression of miR-409-3p in GC patients did not significantly correlate with age, gender, tumour size, location, differentiation or local invasion. However, miR-409-3p expression was significantly associated with tumor-node-metastasis (TNM) stage and lymph node metastasis status. We found that miR-409-3p expression was gradually decreased in stage I, II, III and IV GC ( Figure 1c) ; however, the only significant difference (P ¼ 0.03) was between stage II and III. Interestingly, it was found that miR-409-3p expression was markedly lowered in GC patients with lymph node metastasis (n ¼ 52) than in those without lymph node metastasis (n ¼ 38; Figure 1d ), suggesting that miR-409-3p might have a suppressive role in lymph node metastasis. In addition, the expression of miR-409-3p in various human GC cell lines was determined. miR-409-3p had a lower basal level of expression in HGC-27 and SGC-7901 cell lines, both of which originated from lymph node metastasis sites of GC (Supplementary Figure S2A) .
Overexpression of miR-409 has no effect on GC cell proliferation, but suppresses GC cell migration and invasion in vitro To better understand the biological functions of miR-409, we first constructed a lentivirus vector expressing miR-409, and estab- (Table 1) in GC tissues. Correspondingly, overexpression of miR-409 had no effect on the growth of the GC cells (Supplementary Figure S3B) . miR-409 encodes two mature sequences, miR-409-3p and miR-409-5p. We determined the individual effect of miR-409-3p and miR-409-5p on GC cell growth. As shown in Supplementary Figure S3C , neither miR-409-3p nor miR-409-5p had an influence on GC cell growth. In line with these findings, the growth of GC cells was not affected by the addition of miR-409-3p or miR-409-5p inhibitors (Supplementary Figure S3D) . Intriguingly, overexpression of miR-409 significantly suppressed the migration and invasion of SGC-7901 and HGC-27 cells compared with the control (Figures 2a and b) .
Overexpression of miR-409 suppresses distal pulmonary metastases and peritoneal dissemination in vivo miR-409-3p has been shown to be associated with the depth of invasion and peritoneal dissemination in GC patients, 19 so we examined the effects of miR-409 on distal pulmonary metastases and peritoneal dissemination in vivo. For pulmonary metastasis assays, SGC-7901 cells stably expressing miR-409 were injected into nude mice through the lateral tail vein. Six weeks later, the mice were killed. The lungs were removed and subjected to histological and pathological examination. Intriguingly, the numbers and size of the metastatic nodules in the lung samples were significantly reduced in miR-409 groups when compared with the vector controls (Figure 3a) . For peritoneal dissemination assays, the miR-409 expressing cells of SGC-7901, along with the control cells, were implanted into the peritoneal cavity of mice. After 5 weeks, the results showed that miR-409 had the capability to reduce the peritoneal dissemination, as the number of macroscopic nodules in miR-409 groups was much lower than the vector controls ( Figure 3b ). Of note, we also examined the influence of miR-409 on the local growth in vivo. The data further confirmed that miR-409 did not affect GC cell proliferation (Supplementary Figures S3E and F) . Taken together, these results support the role of miR-409 in the suppression of GC metastasis.
miR-409-3p, but not miR-409-5p, suppresses GC cell migration and invasion To determine which mature sequence of miR-409 is involved in GC cell migration and invasion, we introduced the mimic of miR-409-3p and miR-409-5p into SGC-7901 cells individually. We found that miR-409-3p, but not miR-409-5p, inhibited GC cell migration and invasion ( Figure 4a ). To further support these findings, MKN-45 cells with a relatively high baseline expression of miR-409 were transfected with the miR-409-3p inhibitor and miR-409-5p inhibitor, respectively. The results showed that miR-409-3p inhibitor significantly increased the migration and invasion of MKN-45 cells, whereas miR-409-5p inhibitor had no effect on the migration and invasion of MKN-45 cells (Figure 4b ). These results indicate that miR-409-3p, not miR-409-5p, inhibits the migration and invasion of GC cells.
miR-409-3p downregulates RDX expression by directly targeting its 3
0 UTR A miRNA usually exerts its function by suppressing the expression of target genes. Therefore, our next aim was to investigate the targets of miR-409 that contributed to its anti-metastatic function.
We examined the gene expression profile of miR-409 overexpressing and control cells using an mRNA microarray. The results revealed that 476 genes were downregulated by miR-409 (data not shown). When the result was compared with the predicted targets from the bioinformatics algorithms of TargetScan (www.targetscan.org), six genes (EXT1, REPS1, RDX, SPRED1, ZFAND5 and ZMIZ1) were identified as the potential targets of miR-409-3p (Supplementary Table S1 ). To determine whether the six genes were regulated by miR-409-3p through direct binding to their 3 0 -UTR, we constructed vectors containing the 3 0 -UTR of each gene, which was individually fused directly downstream of the firefly luciferase gene. The luciferase assays showed that miR-409-3p could reduce the luciferase activities of the 3 0 -UTR of REPS1 and RDX (Supplementary Figure S4) . However, the luciferase activity of RDX showed a more significant decline than REPS1, and only RDX has been reported to be associated with cancer metastasis, 20 ,21 so we focused on RDX for further research. We constructed a vector containing mutant 3 0 -UTR of RDX fused directly downstream of the firefly luciferase gene (Figure 5a ). For the luciferase assays, the wild-type or mutant vector was cotransfected into HEK293T cells with a negative control, miR-409-3p or miR-409-5p mimic. As shown in Figure 5b , miR-409-3p, but not miR-409-5p, sharply decreased the relative luciferase miR-409 targets RDX expression in GC B Zheng et al activity of the wild-type 3 0 -UTR of RDX, whereas the luciferase activity of the mutant 3 0 -UTR was not significantly changed, indicating that such regulation was sequence-specific. In addition, western blot analysis demonstrated that the stably expressed miR-409 significantly inhibited the endogenous protein level of RDX (Figure 5c ). Furthermore, transient transfection with miR-409-3p mimic in SGC-7901 cells resulted in a clear attenuation of RDX protein expression, whereas no distinct changes were detected after transfection with miR-409-5p mimic (Figure 5d ). We also found that inhibition of miR-409-3p, but not miR-409-5p, could increase the expression of RDX in GC cells (Figure 5d ). Interestingly, the mRNA level of RDX was significantly decreased by miR-409-3p, but not miR-409-5p, in SGC-7901 cells, whereas no significant change was observed in HGC-27 cells when transfected with either miR-409-3p or miR-409-5p mimic ( Supplementary  Figures S5A and B) . These results suggested that miR-409 regulates RDX expression both through induced-mRNA degradation and translational repression, which was consistent with a recent report showing that the repression of mRNA by miRNAs was cellular-context dependent. 22, 23 Next, we examined both the mRNA and protein expression of RDX in GC tissues, which had been used to detect the expression of miR-409-3p; however, we found that RDX had no significant reverse relationship with miR-409-3p expression (Supplementary Figures S6A and B) .
RDX promotes the migration and invasion of GC cells and the enhanced expression of RDX can block miR-409-induced migration and invasion suppression RDX is a member of the ezrin --RDX --moesin family that has an important role in cancer progression and metastasis. 20, 24, 25 To determine whether downregulation of RDX was involved in miR-409-mediated suppression of migration and invasion, we first analysed the effects of RDX in GC cells. As shown in Figures 6a  and b , transfection of a specific small interfering RNA against RDX into SGC-7901 and HGC-27 cells led to sharply decreased RDX expression. Moreover, silencing of RDX significantly inhibited the migration and invasion of GC cells (Figures 6c and d) , which phenocopied the migration and invasion-inhibitory effects of miR-409. In addition, we introduced a construct expressing RDX into miR-409 stably expressing cell lines of SGC-7901. The restoration of RDX expression in the stable cell lines was confirmed by western blot (Figure 6e ). Restoration of RDX significantly increased the migratory and invasive capabilities of GC cells. Importantly, we showed that restoration of RDX could significantly reverse the migration and invasion suppression imposed by miR-409 (Figure 6f ). Collectively, our data suggested that inhibition of RDX expression by miR-409 was, at least in part, responsible for miR-409 suppression of cell migration and invasion and, consequently, lymph node metastasis in human GC.
DISCUSSION
The majority of cancer-related deaths are caused by metastasis. Therefore, developing an effective intervention targeting metastatic disease should improve the mortality of cancer patients. Mounting evidence suggests an important role for miRNAs in the regulation of cancer metastasis, including miR-31, 20 miR-151, 26 miR-34a, 27 miR-146a 17 and miR-92a. 28 However, the functional role of miRNAs in GC metastasis is still largely unknown. In this study, we demonstrated that miR-409-3p was frequently downregulated in human GC and that its downregulation was significantly associated with clinical stage and lymph node metastasis. Enforced expression of miR-409 could suppress the migration, invasion and metastasis of GC cells in vitro and in vivo. We further identified RDX, a putative pro-metastatic gene, 20, 25 as a direct functional target of miR-409. To our knowledge, this is the first study to explore the role of miR-409 in cancer, and our results indicate that miR-409 acts to suppress metastasis in GC.
Although the expression and functions of some miRNAs have been characterised in GC, 29 --31 studies on the relationship Metastasis to lymph nodes is a frequent event in early GC metastasis, and it is an important prognostic indicator for patient outcome. 4, 32 In our study, we found that downregulation of miR-409-3p was significantly associated with lymph node metastasis in GC patients. Interestingly, SGC-7901 and HGC-27 cell lines, which both originate from the lymph node metastatic locus of GC patients, had relatively lower miR-409-3p levels compared with other cell lines not originating from lymph node metastatic sites. Consistent with our results, an elegant microarray analysis 19 in GC tissues showed that miR-409-3p was associated with clinicopathological metastasis-related parameters such as peritoneal dissemination, depth of tumour invasion and lymph node metastasis. Recently, it was reported that miR-409 may be subjected to epigenetic modulation in GC, which in turn may be responsible for miR-409-3p downregulation in GC. 33 Taken together, these results suggest that reduced miR-409-3p is a frequent event in human GC and that patients with downregulated miR-409-3p are prone to lymph node metastasis.
The capability of cell migration and invasion is considered to be one of the important determinants in the process of cancer metastasis. Although a large number of coding genes are reported to be involved in the course of this disease, the molecular mechanisms are still largely unknown. Recently, compelling evidence has shown that miRNAs exert significant impacts on the migration, invasion and metastasis of human cancers, and even demonstrates that miRNAs have the therapeutic potential. 34 However, only a few miRNAs (miR-218, 15 miR-516a-3p, 16 miR-107, 35 Let-7f 18 ) have been reported to be involved in the metastasis of GC. So identifying more miRNAs related to GC metastasis is important for clarifying the complicated mechanisms underlying GC metastasis. In this study, we found that miR-409 could reduce the GC cell migration and invasion in vitro. Moreover, we demonstrated that miR-409 possessed the capacity to suppress distal pulmonary metastasis and peritoneal spreading in vivo, without affecting cell proliferation. Taken together, these findings suggested that miR-409 acts as a new anti-metastatic miRNA in GC and that miR-409 may have therapeutic potential in GC patients with metastasis.
RDX belongs to the ezrin --RDX --moesin family, which act as membrane --cytoskeletal crosslinkers and signal transducers in mediating cytoskeletal remodelling. 36 The ezrin --RDX --moesin family members can regulate multiple cell functions, 37 ,38 such as cell shape maintenance, formation of microvilli, cell adhesion, cell migration and cell polarity. Mounting evidence suggests that the ezrin --RDX --moesin family members have an important role in tumour metastasis. 21 RDX was originally identified as a constituent of adherence junctions in the livers of rats, 36 and it has more recently been implicated in cancer progression and metastasis. 20, 24, 25, 39 It has been reported that RDX may cooperate with ITGA5 and RhoA to affect three distinct steps in the invasionmetastasis cascade in vivo, local invasion, early post-intravasation events and metastatic colonisation. 25 Silencing of RDX has also been found to suppress the migration and invasion of GC cells. 40 Together with our findings, these results suggested that RDX could act as a pro-metastatic factor in various cancers. Our study indicates that miR-409 can regulate the expression of RDX in GC. Another report indicates that the anti-metastatic miRNA miR-31 inhibits breast cancer metastasis by targeting RDX and that re-expression of RDX could partially reverse the miR-31-imposed invasion defects. Together, these results suggest that RDX is regulated by miRNAs and that downregulation of these miRNAs in cancer may facilitate the expression of RDX, resulting in enhanced metastasis of the cancer.
In summary, we have identified an important anti-metastatic miRNA, miR-409, the mature 3p sequence of which is frequently underexpressed and associated with lymph node metastasis in GC. Re-expression of miR-409 suppresses GC cell invasion, metastasis and peritoneal dissemination through negative regulation of RDX expression. Expanding on the role miRNAs have in GC lymph node metastasis will improve our understanding of the complicated mechanisms underlying GC progression, and may promote the development of new therapeutic regimens for treating advanced GC. RNA extraction and quantitative real-time PCR Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). cDNA was synthesised with the PrimeScript RT reagent Kit (TaKaRa, Dalian, China). Quantitative RT--PCR assays to detect mRNA expression were conducted using SYBR Premix Ex Taq (TaKaRa), with b-actin as an internal control. TaqMan miRNA assays (Applied Biosystems, Foster City, CA, USA) were used to quantitate the expression level of mature miR-409-3p according to the manufacturer's protocol, with U6 small nuclear RNA as an internal control.
MATERIALS AND METHODS

Vector constructs
The pri-miR-409 sequence was amplified from normal human genomic DNA and inserted into the pWPXL vector (a generous gift from Dr T Didier). The RDX expression vector was generated by inserting its open reading frame into the pWPXL vector. The wild type and mutated 3 0 -UTR of RDX were cloned downstream of a cytomegalovirus promoter-driven firefly luciferase cassette in a pCDNA3.0 vector.
Lentivirus production and transduction pWPXL-miR-409 was co-transfected with the packaging plasmids psPAX2 and pMDG2 into HEK293T cells using Lipofectamine 2000 (Invitrogen). Virus particles were collected 48 h later and added to the media of SGC-7901 and HGC-27 cells with 6 mg/ml Polybrene (Sigma, St Louis, MO, USA).
Oligonucleotide transfection miR-409-3p and miR-409-5p mimics were synthesised by Genepharma (Shanghai, China). miR-409-3p inhibitor, miR-409-5p inhibitor (2 0 -O-methyl modification) and small interfering RNA against RDX were synthesised by Ribobio (Guangzhou, China). The sequence of the small interfering RNA targeting RDX is 5 0 -GCCAGAGATGAAACCAAGAAA-3 0 . Oligonucleotide transfection was performed with Lipofectamine 2000 reagents according to the manufacturer's instructions. For proliferation assays, cells were trypsinised 24 h after transfection. For migration, invasion and western blot assays, cells were collected 48 h after transfection.
Cell migration and invasion assays
For the migration assays, 5 Â 10 4 cells in serum-free media were placed into the upper chamber of an insert (8-mm pore size; BD Bioscience, Franklin Lakes, NJ, USA). For the invasion assays, 1 Â 10 5 cells in serum-free media were placed into the upper chamber of an insert coated with Matrigel (BD Bioscience, Woburn, MA, USA). Media containing 10% foetal bovine serum were added to the lower chamber. After several hours of incubation, the cells remaining on the upper membrane were removed with cotton wool, whereas the cells that had migrated or invaded through the membrane were stained with 20% methanol and 0.1% crystal violet, imaged, and counted using an IX71 inverted microscope (Olympus, Tokyo, Japan). Experiments were independently repeated three times.
Luciferase assays HEK293T cells of 8 Â 10 3 were plated into 96-well plates. After 24-h incubation, a mixture of 100-ng pLUC --3 0 -UTR, 5-pmol negative control , miR-409-3p mimic or miR-409-5p mimic was cotransfected with 20 ng Renilla into HEK293T cells using Lipofectamine 2000. Forty-eight hours after transfection, firefly and Renilla luciferase activities were measured with a Dual-Luciferase Reporter System (Promega, Madison, WI, USA). The transfection efficiency was normalised by cotransfection with a Renilla reporter vector.
In vivo metastasis assays
For in vivo pulmonary metastasis assays, 1 Â 10 6 SGC-7901 cells infected with miR-409 or mock vector, respectively, were suspended in 200 ml phosphate-buffered saline for each mouse. Nude mice (six per group, 5-week-old BALB/c-nu/nu) were inoculated through the lateral tail vein. After 6 weeks, the mice were killed. Their lungs were dissected and fixed with phosphate-buffered neutral formalin before paraffin embedding. The tissue was then sectioned and stained in haematoxylin and eosin . For peritoneal dissemination assays, we performed intraperitoneal injection in mice (nine per group, 1.5 Â 10 6 cells for each mouse). Five weeks later, the mice were killed. The macroscopic nodules in abdominal cavity were counted; the fused nodules were calculated as a single nodule. To test the tumourigenicity, SGC-7901 cells infected with miR-409 or mock vector, respectively, were subcutaneously injected into mice (six per group, 3 Â 10 6 cells for each mouse). Four weeks later, the mice were killed. Mice were manipulated and housed according to protocols approved by the Shanghai Medical Experimental Animal Care Commission.
Western blot analysis
Proteins were separated on SDS --polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). The membrane was blocked with 5% non-fat milk and incubated with rabbit anti-RDX monoclonal antibody (1:1000; Cell Signaling Technology, Danvers, MA, USA) and mouse anti-b-actin monoclonal antibody (1:10 000; Sigma). The proteins were detected with enhanced chemiluminescence reagents (Pierce, Rockford, IL, USA).
Statistical analysis
Data were presented as mean ± s.e.m. Unless otherwise noted, Student's t-test was used for comparisons, with Po0.05 considered significant.
